Soligenix Inc. (NASDAQ: SNGX) Advances Phase 3 Replication Study for Early-Stage Cutaneous T-Cell Lymphoma Treatment
Soligenix is enrolling patients in its FLASH2 study, with a formal interim analysis anticipated early in 2026. SNGX’s HyBryte is…
Soligenix is enrolling patients in its FLASH2 study, with a formal interim analysis anticipated early in 2026. SNGX’s HyBryte is…
Mullen Automotive (NASDAQ: MULN) announced that its Mullen and Bollinger commercial electric vehicles are fully assembled in the United States…
Solving the ongoing hospitality labor crisis can create billion-dollar companies Nightfood’s unique RaaS business model lowers barriers to entry while…
IBN ("InvestorBrandNetwork"), an innovative corporate communications firm and content distributor, has announced its collaboration with Centri Business Consulting, LLC for…
Quant Strats USA 2025, held on March 11 at Quorum by Convene in New York, brought together over 380 professionals…
KRTL HOLDING Group (OTC: KRTL), a diversified holding company focused on biotechnology innovation, global API sourcing, and cross-border distribution solutions,…
Massimo Group (NASDAQ: MAMO), a U.S. manufacturer of powersports vehicles, announced the launch of its new online sales platform, marking a…
The company will present at the Jones Las Vegas Technology and Innovation Conference on April 8-9, to update investors on…
Brera Holdings (NASDAQ: BREA), an Ireland-based company focused on expanding a global portfolio of men's and women's sports clubs through…
The ZJ Alternative Products Expo will be held from April 3-5, 2025, at the Mana Wynwood Convention Center in Miami.…